Eupraxia Pharmaceuticals Inc. (EPRX)
NASDAQ: EPRX · Real-Time Price · USD
5.40
+0.02 (0.35%)
Jul 16, 2025, 4:00 PM - Market closed
Eupraxia Pharmaceuticals Market Cap
Eupraxia Pharmaceuticals has a market cap or net worth of $194.49 million as of July 16, 2025. Its market cap has increased by 113.50% in one year.
Market Cap
194.49M
Enterprise Value
197.36M
1-Year Change
113.50%
Ranking
Category
Stock Price
5.40
Market Cap Chart
Since March 9, 2021, Eupraxia Pharmaceuticals's market cap has increased from $61.62M to $194.49M, an increase of 215.64%. That is a compound annual growth rate of 30.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 15, 2025 | 191.49M | 71.50% |
| Dec 31, 2024 | 111.66M | 0.72% |
| Dec 29, 2023 | 110.86M | 90.37% |
| Dec 30, 2022 | 58.23M | 111.19% |
| Dec 31, 2021 | 27.57M | -55.25% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 717.60B |
| Johnson & Johnson | 377.32B |
| AbbVie | 338.30B |
| Novo Nordisk | 308.09B |
| UnitedHealth Group | 272.67B |
| Novartis AG | 237.08B |
| Abbott Laboratories | 229.71B |
| AstraZeneca | 222.35B |